Close

Please fill all fields and submit the form.

Name:
Email:

Phone:

Notes:



Close

Please fill out all fields in the form. Please be as detailed as possible. We will respond with pricing and availability within 1-2 business days.

Name:
Company/Institution:

Phone:
Email:

Disease:

Organ/Tissue type:

Format:

Number of patients/donors required for the study:

Clinical Specifications:

Applications/Research topic:

New Lentivirus Vectors for Stem Cell Research

03/23/2009

Vectors and Ready-to-use Viruses for Generation of Induced Pluripotent Stem Cells


Capital Biosciences is offering new line of lentiviral vectors and ready-to-use virus stocks for the stem cells research.

Lentivirlal vectors with three different promoters (CMV, PGK and UbC) have been developed for the virus particle production.

Pre-made viruses can be used directly for Pluripotent Stem Cells induction.

Induced Pluripotent Stem Cells (iPS cells or iPSCs) are derived from human somatic cells through genetic modification and integration of specific DNA-transcription factors to reprogram adult human cells to a pluripotent state.

It has been demonstrated that Sox2, c-myc, Lin28, KLF4, and especially Oct4 and Nanog play essential roles in the induction of pluripotent stem cells. Both recombinant adenoviral and lentiviral vectors have been found to be efficient and effective for the generation of iPSCs.